CD8A and neoplasm: Some Tregs undergo a transition from an anti-inflammatory state to a pro-inflammatory state; weaken the response of Th1 and CD8 T cells, which are effector T cells involved in anti-tumor responses, and produce inflammatory factors such as IL-10 and TGF-β